Predictors of subjective and objective quality of life in outpatients with schizophrenia

Aim:  In recent years, greater attention has been given to quality of life (QOL) in schizophrenia and several studies reported that negative and depressive symptoms and cognitive dysfunction are related to patient QOL. But because a variety of QOL measures have been used in the previous studies, there seems to be no unanimous predictors for subjective and objective QOL. The purpose of the present study was to elucidate the relationship between clinical variables and subjective and objective QOL in outpatients with schizophrenia, using schizophrenia disease‐specific QOL measures. Particular attention was paid to cognitive function as a predictor of QOL.

[1]  Y. Kaneda,et al.  Subjective and objective quality of life, levels of life skills, and their clinical determinants in outpatients with schizophrenia , 2008, Psychiatry Research.

[2]  W. Fleischhacker,et al.  Cognitive impairment in schizophrenia: Clinical ratings are not a suitable alternative to neuropsychological testing , 2007, Schizophrenia Research.

[3]  Peter B. Jones,et al.  Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). , 2006, Archives of general psychiatry.

[4]  Y. Kaneda,et al.  Effect of antipsychotic replacement with quetiapine on the symptoms and quality of life of schizophrenic patients with extrapyramidal symptoms , 2006, Human psychopharmacology.

[5]  Y. Kaneda,et al.  Subjective and Objective Measures of Quality of Life Have Different Predictors for People with Schizophrenia , 2006, Psychological reports.

[6]  W. Fleischhacker,et al.  Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder , 2006, European Archives of Psychiatry and Clinical Neuroscience.

[7]  C. Mercier,et al.  Socio-demographic and clinical predictors of quality of life in patients with schizophrenia or schizo-affective disorder , 2005, Psychiatry Research.

[8]  M. Lambert,et al.  PANSS Syndromes and Quality of Life in Schizophrenia , 2005, Psychopathology.

[9]  S. Strejilevich,et al.  Lack of extrapyramidal side effects predicts quality of life in outpatients treated with clozapine or with typical antipsychotics , 2005, Psychiatry Research.

[10]  Philip D. Harvey,et al.  The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery , 2004, Schizophrenia Research.

[11]  C. Lançon,et al.  Depression and subjective quality of life in chronic phase schizophrenic patients , 2003, Acta psychiatrica Scandinavica.

[12]  I. Glick,et al.  A meta-analysis of the efficacy of second-generation antipsychotics , 2003, Schizophrenia Research.

[13]  Y. Kaneda,et al.  Schizophrenia Quality of Life Scale: validation of the Japanese version , 2002, Psychiatry Research.

[14]  Thomas E. Smith,et al.  Quality of life in schizophrenia: contributions of anxiety and depression , 2001, Schizophrenia Research.

[15]  P. Fitzgerald,et al.  Subject and observer‐rated quality of life in schizophrenia , 2001, Acta psychiatrica Scandinavica.

[16]  J. Endicott,et al.  Differences in quality of life domains and psychopathologic and psychosocial factors in psychiatric patients. , 2000, The Journal of clinical psychiatry.

[17]  Herbert Y Meltzer,et al.  The role of cognition in vocational functioning in schizophrenia , 2000, Schizophrenia Research.

[18]  A. Malla,et al.  The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the Quality of Life Scale , 2000, Acta psychiatrica Scandinavica.

[19]  G. Wilkinson,et al.  Self-report quality of life measure for people with schizophrenia: the SQLS. , 2000, The British journal of psychiatry : the journal of mental science.

[20]  Z. Cernovsky,et al.  Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life , 2000, Schizophrenia Research.

[21]  Y. Kaneda,et al.  Psychometric properties of the Japanese version of the Calgary Depression Scale for Schizophrenics. , 2000, The Journal of nervous and mental disease.

[22]  N C Andreasen,et al.  Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life. , 1998, The American journal of psychiatry.

[23]  F. Dickerson,et al.  Subjective quality of life in out‐patients with schizophrenia: clinical and utilization correlates , 1998, Acta psychiatrica Scandinavica.

[24]  M. Roe,et al.  Quality of life in schizophrenia: insight and subjective response to neuroleptics. , 1998, The Journal of nervous and mental disease.

[25]  R. Heslegrave,et al.  Quality of life measurement in schizophrenia: reconciling the quest for subjectivity with the question of reliability , 1998, Psychological Medicine.

[26]  Alexander L. Miller,et al.  The functional significance of symptomatology and cognitive function in schizophrenia , 1997, Schizophrenia Research.

[27]  A. Lane,et al.  Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia , 1996, Acta psychiatrica Scandinavica.

[28]  Michael F. Green,et al.  What are the functional consequences of neurocognitive deficits in schizophrenia? , 1996, The American journal of psychiatry.

[29]  M. Bell,et al.  Concurrent validity of the cognitive component of schizophrenia: Relationship of PANSS scores to neuropsychological assessments , 1994, Psychiatry Research.

[30]  M. Bell,et al.  Five-component model of schizophrenia: Assessing the factorial invariance of the positive and negative syndrome scale , 1994, Psychiatry Research.

[31]  H. Y. Meltzer.  Dimensions of Outcome with Clozapine , 1992, British Journal of Psychiatry.

[32]  D. Pickar,et al.  National Institute of Mental Health longitudinal study of chronic schizophrenia. Prognosis and predictors of outcome. , 1991, Archives of general psychiatry.

[33]  Brian Coe,et al.  The positive and the negative , 1983, Nature.

[34]  G. Chelune,et al.  Using neuropsychological and personality tests to assess the likelihood of patient employment. , 1978, The Journal of nervous and mental disease.

[35]  N. Andreasen,et al.  Two-Year Outcome in First-Episode Schizophrenia: Predictive Value of Symptoms for Quality of Life , 2004 .

[36]  R. Heslegrave,et al.  A conceptual model of quality of life in schizophrenia: Description and preliminary clinical validation , 2004, Quality of Life Research.

[37]  H. Meltzer,et al.  The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. , 1999, Schizophrenia bulletin.

[38]  H. Meltzer.  Outcome in schizophrenia: beyond symptom reduction. , 1999, The Journal of clinical psychiatry.

[39]  H. Meltzer,et al.  Neuropsychologic deficits in schizophrenia : Relation to social function and effect of antipsychotic drug treatment , 1996 .

[40]  A. Lehman,et al.  A Quality of Life Interview for the chronically mentally ill. , 1988 .

[41]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.

[42]  W T Carpenter,et al.  The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. , 1984, Schizophrenia bulletin.

[43]  C. L. Callahan,et al.  The quality of life. , 1970, Nursing outlook.